StockData
AVITA Medical, Inc. logo

AVITA Medical, Inc. (RCEL) income statement

RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$16.83+1.06 (+6.72%)

Close on Nov 18, 2026Market cap $520.50MP/E –Yield –

AVITA Medical, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
81.6%
Operating margin
-46.6%
Net margin
-57.0%
Return on equity, FY2025
799.7%

Financial strength

Current ratio
0.41
Debt to equity
–
Debt to assets
–
Cash to current liabilities
13.3%

Valuation

P/E ratio
–
Price to sales
6.88
Price to book
–
Dividend yield
–

See a number that looks wrong?